ChemoCentryx, Inc.
C5aR antagonists
Last updated:
Abstract:
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
Status:
Grant
Type:
Utility
Filling date:
9 Jul 2018
Issue date:
26 May 2020